A major new scientific review of evidence published in the journal Addiction has identified three top strategies for quitting smoking.
BioMarin shakes up executive team, tapping notable dealmaker James Sabry
BioMarin is bringing prominent dealmaker James Sabry onto its executive team, along with Amgen rare disease veteran Greg Friberg. Sabry will start on Oct. 7